About AgnoSci
Pioneering In Vitro Diagnostics for Infectious Pathogen Detection
AgnoSci is dedicated to developing innovative in vitro diagnostic (IVD) solutions for infectious pathogen detection. By leveraging multiomics technologies and artificial intelligence, we identify and validate novel biomarkers to create rapid, accurate diagnostic tools that transform forensic science and infectious disease detection.
What We Do
-
Multi-omics analysis (genomics, transcriptomics, proteomics, metabolomics)
AI-powered pattern recognition for biomarker identification
Comprehensive validation of death-associated molecular patterns
Novel pathogen signature detection
Integration of multiple data streams for enhanced accuracy
-
Translation of validated biomarkers into diagnostic assays
Development of rapid, point-of-need testing solutions
Creation of multiplexed detection panels
Optimization for field deployment
Regulatory-compliant development process
-
Molecular diagnostic tools for cause of death determination
Rapid pathogen detection and identification
Systematic biomarker screening
Comprehensive molecular profiling
Integration with traditional forensic methods
Strategy
-
Discover
Multi-omics data collection and analysis
AI-driven biomarker identification
Pattern recognition across large datasets
Statistical validation of findings
-
Develop
Translation of biomarkers into IVD formats
Assay optimization and validation
Protocol standardization
Performance verification
-
Implement
Field testing and validation
Quality control implementation
User training and support
Continuous performance monitoring
Technology Platform
-
Next-generation sequencing
Proteomics profiling
Metabolomics analysis
Transcriptomics assessment
-
Machine learning algorithms for pattern recognition
Deep learning for biomarker identification
Predictive modeling
Automated data analysis
Continuous learning systems
-
Rapid assay prototyping
Multiplexed detection systems
Point-of-need format optimization
Stability testing
Performance validation